Datapoint: Highmark Saves $3M With First CivicaRx Launch

Highmark Inc. members who are taking abiraterone acetate (the generic name for Johnson & Johnson’s Zytiga) have saved an average of $90 per month since a cheaper version of the oncology medication became available through CivicaScript, according to a May 29 press release. Highmark and other Blues plans founded CivicaScript in 2020 to develop generic drugs, including abiraterone acetate, which was the first CivicaScript medication to hit the market in 2022. Since Highmark began prescribing the generic abiraterone acetate in September 2023, the insurer noted its members, group customers and the plan itself has saved nearly $3 million. Highmark said CivicaScript will continue to launch generics, including outpatient drugs that treat specialty areas and chronic health conditions. Highmark currently serves 2,459,151 lives under the pharmacy benefit.

SOURCE: MMIT Analytics, as of 6/3/24

0 Comments
© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 12

Datapoint: Centene to Expand Cityblock Partnership to Florida

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 11

Datapoint: SCAN Wins Stars Challenge Against CMS

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 10

Datapoint: Blue Cross and Blue Shield of Kansas City to Exit MA Market

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today